Skip To Main Content
Roel van Kampen on Muck Rack

Roel van Kampen

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Roel van Kampen’s profile

Articles by Roel van Kampen

Nivolumab consolidation in patients with double and triple hit high-grade B-cell lymphoma in complete metabolic remission after DA-EPOCH-R

|
By Erik van Werkhoven, Marjolein van der Poel, Yorick Sandberg, Pim Mutsaers, Djamila Issa, Aart Beeker, Yavuz M. Bilgin, Lara H. Böhmer, Laurens Nieuwenhuizen, Wendy Stevens, Rogier Mous, Joost Vermaat, Otto Visser, Josée M Zijlstra, Ben G.J.C. Zwezerijnen, Bart de Keizer, Robby E. Kibbelaar, Lianne Koens, Liping Fu, Daphne de Jong, David Kurtz Verified, Marcel Nijland, Marie José Kersten, Martine Chamuleau, A. Vera de Jonge, Koen de Heer, Clara P. W. Klerk, Rozemarijn van Rijn, Rob Fijnheer, Vibeke K. J. Vergote, Roel van Kampen, Marc Durian, Tjeerd Snijders, Anne I. J. Arens, Danielle van Assema, Henk Hofwegen, Helma Zanders, Brigitta A. G. Schuthof
| Nature Verified
Abstract Patients with high-grade B-cell lymphoma harboring MYC, BCL2, and/or BCL6 rearrangements (HGBL-DH/TH) frequently relapse after induction chemoimmunotherapy. High MYC is claimed to contribute to immune escape. We evaluated consolidation with PD-1 blockade in patients with HGBL-DH/TH in complete metabolic remission (CMR) after DA-EPOCH-R.
Open in Who Shared Issue with article?
Show More